Potential indications: dry macular degeneration, wet macular degeneration

Description:

1. For the treatment of dry age-related macular degeneration.

2. Fusion protein molecule of anti VEGF nano antibody and complement binding domain. It is better to treat amd patients from the aspects of anti angiogenesis, anti accumulation of complement metabolites and anti-inflammatory.

3. Compared with wet AMD, dry amd has no effective treatment drugs, and the patient base and disease burden are huge.

4. Using yeast expression, the production cost is low.